Standout Papers

Secukinumab, a human anti-IL-17A monoclonal antibody, for mo... 2004 2026 2011 2018 1.1k
  1. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial (2012)
    Wolfgang Hueber, Bruce E. Sands et al. Gut
  2. Reduced Paneth cell α-defensins in ileal Crohn's disease (2005)
    Jan Wehkamp, Nita H. Salzman et al. Proceedings of the National Academy of Sciences
  3. NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression (2004)
    Jan Wehkamp, Jürgen Harder et al. Gut

Immediate Impact

2 by Nobel laureates 48 from Science/Nature 126 standout
Sub-graph 1 of 16

Citing Papers

Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease
2023 Standout
Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome
2022 Standout
3 intermediate papers

Works of Jan Wehkamp being referenced

Management of Crohn's disease – are guidelines transferred to clinical practice?
2015
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout

Author Peers

Author Last Decade Papers Cites
Jan Wehkamp 2885 3593 3096 4466 157 11.0k
Klaus Fellermann 1538 1929 2543 2483 101 6.8k
Nita H. Salzman 1569 2463 1187 4614 97 9.0k
Martin F. Kagnoff 1887 8081 2566 4559 205 18.7k
André J. Ouellette 4956 2991 800 4948 140 9.7k
Mathias Chamaillard 1060 8239 4890 6183 114 16.9k
Mathias W. Hornef 718 2687 959 3588 142 8.9k
Stephen E. Girardin 1847 11530 2158 8281 173 21.5k
Jerrold Weiss 3175 5987 1164 4399 178 10.9k
Kelly D. Smith 1401 7690 782 3382 120 13.6k
Moshe Arditi 1787 8938 998 6294 210 18.4k

All Works

Loading papers...

Rankless by CCL
2026